RODNEY SESSOMS: Open Payments
NPI 1558314476 · CLINTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 30 payments from 11 companies in 2025. Trend: 2023 $920 · 2024 $942 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $216 |
| AstraZeneca Pharmaceuticals LP | 4 | $147 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Amgen Inc. | 3 | $50 |
| Novo Nordisk Inc | 2 | $42 |
| Exact Sciences Corporation | 2 | $34 |
| ABBVIE INC. | 2 | $34 |
| Lundbeck LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: CAPLYTA, AIRSUPRA, TRELEGY ELLIPTA, OTEZLA, FARXIGA, VRAYLAR, Ozempic, REXULTI.
Industry payments across NC — which companies pay providers there.
